AAWHOTCMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
Ascend Wellness Holdings, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 12, 2026
$0.39−0.00 (-0.73%)
Close on Oct 19, 2026
- Market cap
- $79.60M
- P/E (TTM)
- –
- Dividend yield
- –
Ascend Wellness statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Medicinal Chemicals & Botanical Products companies for comparison
Valuation
| Measure | Ascend Wellness | Industry median |
|---|---|---|
| Market Cap | $79.68M | $166.30M |
| Enterprise Value | $332.33M | $88.19M |
| PS Ratio | 0.16 | 3.65 |
| P/OCF Ratio | 4.59 | 12.98 |
Enterprise value
| Measure | Ascend Wellness | Industry median |
|---|---|---|
| EV / Sales | 0.68 | 2.51 |
| EV / EBITDA | 6.85 | 14.65 |
Income (trailing twelve months)
| Measure | Ascend Wellness | Industry median |
|---|---|---|
| Revenue | $488.33M | $58.34M |
| Gross Profit | $179.10M | $105.94M |
| Operating Income | -$10.67M | -$21.40M |
| Pretax Income | -$79.13M | -$14.34M |
| EBITDA | $48.52M | -$16.91M |
Margins
| Measure | Ascend Wellness | Industry median |
|---|---|---|
| Gross Margin | 36.7% | 52.9% |
| Operating Margin | -2.18% | -44.0% |
| Pretax Margin | -16.2% | -13.3% |
| EBITDA Margin | 9.94% | -30.2% |
| FCF Margin | -1.42% | -9.27% |
Returns
| Measure | Ascend Wellness | Industry median |
|---|---|---|
| Return on Invested Capital (ROIC) | -3.77% | -32.4% |
| Return on Capital Employed (ROCE) | -1.38% | -38.1% |
Growth
| Measure | Ascend Wellness | Industry median |
|---|---|---|
| Revenue Growth (YoY) | -8.37% | 5.96% |
| FCF Growth (YoY) | -118.2% | 2.34% |
| Revenue Growth (3Y CAGR) | 7.24% | 2.25% |
| Revenue Growth (5Y CAGR) | 28.3% | 6.48% |
Balance sheet
| Measure | Ascend Wellness | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $67.00M | $61.43M |
| Total Debt | $318.83M | $118.52M |
| Net Cash (Debt) | -$251.83M | $15.35M |
| Net Cash Per Share | -$1.24 | $0.66 |
| Equity (Book Value) | -$85.91M | $49.09M |
| Book Value Per Share | -$0.42 | $1.37 |
| Tangible Book Value | -$347.24M | $23.52M |
| Working Capital | $74.22M | $76.81M |
Financial position
| Measure | Ascend Wellness | Industry median |
|---|---|---|
| Current Ratio | 1.66 | 3.34 |
| Quick Ratio | 0.83 | 2.44 |
| Debt / EBITDA | 6.57 | 3.44 |
| Net Debt / EBITDA | 5.19 | 2.36 |
| Interest Coverage | -0.15 | -6.26 |
Cash flow (trailing twelve months)
| Measure | Ascend Wellness | Industry median |
|---|---|---|
| Operating Cash Flow | $17.35M | -$12.35M |
| Capital Expenditures | -$24.30M | -$1.08M |
| Free Cash Flow | -$6.95M | -$20.22M |
| FCF Per Share | -$0.03 | -$0.42 |
Efficiency
| Measure | Ascend Wellness | Industry median |
|---|---|---|
| Asset Turnover | 0.54 | 0.39 |
| Inventory Turnover | 3.76 | 2.70 |
| Revenue Per Employee | $212.32K | $404.87K |
| Employee Count | 2,300 | 74 |
Dividends and yields
| Measure | Ascend Wellness | Industry median |
|---|---|---|
| FCF Yield | -8.72% | -8.72% |
| Buyback Yield | 1.65% | -0.59% |
| Shareholder Yield | 1.65% | 0.00% |
Shares
| Measure | Ascend Wellness | Industry median |
|---|---|---|
| Shares Outstanding | 203,213,000 | 58,127,000 |
| Shares Change (YoY) | -3.11% | 10.9% |
| Float | 203,213,000 | 49,136,700 |
| Shares Held by Insiders | 0.00% | 11.6% |
Taxes
| Measure | Ascend Wellness | Industry median |
|---|---|---|
| Income Tax | $34.70M | $79.87K |
Scores
| Measure | Ascend Wellness | Industry median |
|---|---|---|
| Altman Z-Score | -0.22 | -0.22 |
Calculated by StockData from Ascend Wellness's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.